The MarketWatch News Department was not involved in the creation of this content. Bridging Bench to Bedside: De--Risking Biotherapeutic Administration via CDMO--Led Clinical--Mimic and In--Use Testing ...

Pharmaceutical dissolution testing plays a critical role in ensuring drug quality, safety, and bioavailability. It evaluates how quickly and effectively an active pharmaceutical ingredient (API) is ...

About a year and a half after telegraphing plans to shift its headquarters from New Jersey to Philadelphia, CDMO Adare Pharma Solutions appears to be turning out the lights at another facility in the ...

The collapse of the Paris Agreement and the unmasking of the net zero illusion were never hard to predict — not for anyone with a shred of intellectual honesty. It didn’t take a fancy research title ...

According to Precedence Research, the global cell and gene therapy CDMO market size is expected to be worth over USD 74.03 billion by 2034, increasing from USD 8.07 billion in 2025. The market is ...

Contract Pharma has long chronicled the evolution of the CDMO, as seen in pieces like The Modern CDMO and CDMOs: The Cornerstone of Biopharmaceutical Innovation, yet once again the goalposts have ...

Viral vector manufacturing continues to face challenges in delivering consistent quality and achieving high productivity at scale. This webinar will highlight how CDMO innovation drives improvements ...

Washington — President Trump directed the Pentagon on Wednesday to resume testing of nuclear weapons "on an equal basis" with other countries' tests, possibly ending a decades-long U.S. pause that ...

"We've halted many years ago, but with others doing testing I think it's appropriate to do so," the president told reporters aboard Air Force One. Experts say that the resumption of testing would be a ...

GYEONGJU, South Korea — President Donald Trump said Wednesday he had instructed the Defense Department to “immediately” start testing nuclear weapons "on an equal basis" with other nations. “Because ...